Difference between revisions of "MALE5:Volunteer Assignments and Opportunities"
Jump to navigation
Jump to search
[checked revision] | [checked revision] |
(3 intermediate revisions by the same user not shown) | |||
Line 6: | Line 6: | ||
To volunteer, please '''[[Mailto:CCGA@cancergenomics.org <u>Contact us</u>]]''' with your page of interest. | To volunteer, please '''[[Mailto:CCGA@cancergenomics.org <u>Contact us</u>]]''' with your page of interest. | ||
+ | |||
+ | __TOC__ | ||
{| class="wikitable" style="margin:auto" | {| class="wikitable" style="margin:auto" | ||
|+<big>WHO Classification of Urinary and Male Genital Tumours (5th Edition) Content</big> | |+<big>WHO Classification of Urinary and Male Genital Tumours (5th Edition) Content</big> | ||
Line 17: | Line 19: | ||
!'''Notes''' | !'''Notes''' | ||
|- | |- | ||
− | |CHAPTER 2 (TUMOURS OF THE KIDNEY) | + | | |
+ | ==== CHAPTER 2 (TUMOURS OF THE KIDNEY) ==== | ||
| | | | ||
---- | ---- | ||
Line 466: | Line 469: | ||
| | | | ||
|- | |- | ||
− | |CHAPTER 3 (TUMOURS OF THE URINARY TRACT) | + | | |
+ | ==== CHAPTER 3 (TUMOURS OF THE URINARY TRACT) ==== | ||
| | | | ||
---- | ---- | ||
Line 695: | Line 699: | ||
| | | | ||
|- | |- | ||
− | |CHAPTER 4 (TUMOURS OF THE PROSTATE) | + | | |
+ | ==== CHAPTER 4 (TUMOURS OF THE PROSTATE) ==== | ||
| | | | ||
---- | ---- | ||
Line 836: | Line 841: | ||
| | | | ||
|- | |- | ||
− | |CHAPTER 5 (TUMOURS OF THE SIMINAL VESICLE) | + | | |
+ | ==== CHAPTER 5 (TUMOURS OF THE SIMINAL VESICLE) ==== | ||
| | | | ||
---- | ---- | ||
Line 900: | Line 906: | ||
| | | | ||
|- | |- | ||
− | |CHAPTER | + | | |
+ | ==== CHAPTER 6 (TUMOURS OF THE TESTIS) ==== | ||
| | | | ||
---- | ---- | ||
Line 1,239: | Line 1,246: | ||
| | | | ||
|- | |- | ||
− | |CHAPTER 7 (TUMOURS OF THE TESTICULAR ADNEXA) | + | | |
+ | ==== CHAPTER 7 (TUMOURS OF THE TESTICULAR ADNEXA) ==== | ||
| | | | ||
---- | ---- | ||
Line 1,468: | Line 1,476: | ||
| | | | ||
|- | |- | ||
− | |CHAPTER 8 (TUMOURS OF THE PENIS AND SCROTUM) | + | | |
+ | ==== CHAPTER 8 (TUMOURS OF THE PENIS AND SCROTUM) ==== | ||
| | | | ||
---- | ---- | ||
Line 1,587: | Line 1,596: | ||
| | | | ||
|- | |- | ||
− | |CHAPTER 9 (NEUROENDOCRINE NEOPLASMS) | + | | |
+ | ==== CHAPTER 9 (NEUROENDOCRINE NEOPLASMS) ==== | ||
| | | | ||
---- | ---- | ||
Line 1,662: | Line 1,672: | ||
| | | | ||
|- | |- | ||
− | |CHAPTER 10 (MESENCHYMAL TUMOURS) | + | | |
+ | ==== CHAPTER 10 (MESENCHYMAL TUMOURS) ==== | ||
| | | | ||
---- | ---- | ||
Line 1,847: | Line 1,858: | ||
| | | | ||
|- | |- | ||
− | |CHAPTER 11 (HAEMATOLYMPHOID TUMOURS) | + | | |
+ | ==== CHAPTER 11 (HAEMATOLYMPHOID TUMOURS) ==== | ||
| | | | ||
---- | ---- | ||
Line 1,911: | Line 1,923: | ||
| | | | ||
|- | |- | ||
− | |CHAPTER 12 (MELANOCYTIC LESIONS) | + | | |
+ | ==== CHAPTER 12 (MELANOCYTIC LESIONS) ==== | ||
| | | | ||
---- | ---- | ||
Line 1,942: | Line 1,955: | ||
| | | | ||
|- | |- | ||
− | |CHAPTER 13 (METASTASES IN THE GENITOURINARY SYSTEM) | + | | |
+ | ==== CHAPTER 13 (METASTASES IN THE GENITOURINARY SYSTEM) ==== | ||
| | | | ||
---- | ---- | ||
Line 1,995: | Line 2,009: | ||
| | | | ||
|- | |- | ||
− | |CHAPTER 14 (GENETIC TUMOUR SYNDROMES OF TEH URINARY AND MALE GENITAL TRACTS) | + | | |
+ | ==== CHAPTER 14 (GENETIC TUMOUR SYNDROMES OF TEH URINARY AND MALE GENITAL TRACTS) ==== | ||
| | | | ||
---- | ---- | ||
Line 2,017: | Line 2,032: | ||
|[[MALE5:Von_Hippel-Lindau_syndrome|Von Hippel-Lindau syndrome]] | |[[MALE5:Von_Hippel-Lindau_syndrome|Von Hippel-Lindau syndrome]] | ||
|Disease | |Disease | ||
− | | | + | |[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship status]] |
− | | | + | |N/A |
− | | | + | |N/A |
− | | | + | |N/A |
− | | | + | |N/A |
− | | | + | |N/A |
− | | | + | |N/A |
− | | | + | |N/A |
|- | |- | ||
|[[MALE5:Birt-Hogg-Dube_syndrome|Birt-Hogg-Dube syndrome]] | |[[MALE5:Birt-Hogg-Dube_syndrome|Birt-Hogg-Dube syndrome]] | ||
Line 2,105: | Line 2,120: | ||
|[[MALE5:Genitourinary_system_and_Lynch_syndrome|Genitourinary system and Lynch syndrome]] | |[[MALE5:Genitourinary_system_and_Lynch_syndrome|Genitourinary system and Lynch syndrome]] | ||
|Disease | |Disease | ||
− | | | + | |[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship status]] |
− | | | + | |N/A |
− | | | + | |N/A |
− | | | + | |N/A |
− | | | + | |N/A |
− | | | + | |N/A |
− | | | + | |N/A |
− | | | + | |N/A |
|- | |- | ||
|[[MALE5:Hereditary_tumour_syndromes_associated_with_homologous_recombination_pathway_mutations|Hereditary tumour syndromes associated with homologous recombination pathway mutations]] | |[[MALE5:Hereditary_tumour_syndromes_associated_with_homologous_recombination_pathway_mutations|Hereditary tumour syndromes associated with homologous recombination pathway mutations]] |
Latest revision as of 14:09, 10 September 2024
Welcome!
For assignments, please see the "Author" column below (highlighted blue).
If empty (no name is present), please volunteer to create content for that disease!
To volunteer, please [Contact us] with your page of interest.